Vol. I  ·  Issue 3  ·  A compendium for the prostate

A daily
compendium for the prostate.

In the male midlife years, benign prostatic hyperplasia is a near-universal physiological development. The published literature is unambiguous on prevalence; the public conversation is curiously quiet.1 ProstaRemedy is the daily publication of a small American imprint, built around six clinically-supported botanicals and micronutrients, dosed at the levels used in the research.2

Subscribe — single edition, $149 Read the Methodology
A distinguished older gentleman, ProstaRemedy hero portrait
i
Manufactured in a GMP-certified U.S. facility1
Composed in Wilmington, Delaware
ii
Six clinically-supported actives, each dosed per published research2
At the levels used in the trials cited
iii
Sixty-day refund window. Returned without question.3
Policy on file with the publisher
iv
Independent third-party verification, each lot4
Certificate of Analysis on request
Chapter I · Reviewed Q2 2026

On benign prostatic hyperplasia
in the male midlife years.2

Benign prostatic hyperplasia is, in the published epidemiology, a near-universal feature of the male midlife years. The literature is unambiguous on prevalence; the popular and clinical conversation has been, until recently, curiously quiet on the daily experience of the men affected.

50a
Percent of men 50+
with measurable BPH
70b
Percent of men 60+
reporting nocturia
3:5c
Ratio reporting
sleep disruption
1.0d
Annual % prostate
growth after 40
  1. a. Berry SJ, et al. J Urol. 1984;132(3):474–479. Autopsy-series prevalence of histologic BPH by decade.
  2. b. Bosch JLHR, et al. BJU Int. 2008. Population-level prevalence of nocturia in older men.
  3. c. Tikkinen KAO, et al. Eur Urol. 2010. Impact of nocturia on sleep architecture in midlife men.
  4. d. Roehrborn CG. Rev Urol. 2005;7(Suppl 9):S3–S14. Long-term natural history of prostate volume.
Chapter II · Reviewed Q2 2026

On the compendium.
Six actives, dosed per published research.

The compendium is composed of six botanical and micronutrient actives, each dosed at the level cited in the published trial from which it is drawn. Saw Palmetto1 to modulate DHT in prostate tissue. Beta-Sitosterol2 and Pygeum3 for complementary mechanisms. Stinging Nettle4 as adjunct support. Zinc5 and Vitamin D36 to address the two near-universal deficiencies of the midlife male population.

320 mg lipidosterolic Saw Palmetto. 100 mg Beta-Sitosterol. 100 mg Pygeum. 120 mg Stinging Nettle root. 15 mg Zinc bisglycinate. 2,000 IU Vitamin D3. The published dose of each active is printed on the bottle and set out in the Materia Medica of the publication.

Read the Materia Medica
ProstaRemedy two-bottle bundle
A note from the editor

For the reader who consults the back of the bottle — and walks away.

No proprietary blends. No combination tablet of twenty fractional doses. No claim made without a published source on file with the editorial office. A short compendium for the subscriber who consults the literature before placing the order.

Meet the Editorial Board
From the Library · Recent filings

Recent filings
in the Library.

The Library collects reviewed articles on prostate physiology, the published literature on the botanicals, and the lifestyle variables most consequential to the readership. Three starting points are listed below.

Men’s Health

The Prostate After 50: What’s Happening, and Why You Probably Weren’t Told

Roughly half of men over 50 develop benign prostatic hyperplasia. Most are quietly suffering with a fixable problem. Here’s the biology and the levers that work.

Continue reading ›
Ingredients

Saw Palmetto: What Thirty Years of Trials Actually Show

The most-studied botanical for prostate health, and one of the most polarised in the literature. The trials, separated from the marketing.

Continue reading ›
Symptoms

Nocturia: The 3 a.m. Wake-Up Most Men Just Accept

Two or three nightly bathroom trips become normal somewhere in your fifties. They do not have to be. The layered approach that actually reduces nocturia.

Continue reading ›
All filings in the Library
Subscriptions · Three editions

Three editions. One compendium.

The published trials report meaningful effect at eight to twelve weeks of continuous use. The annual standing order is, accordingly, the default subscription cadence for new readers.

One bottle
Single edition  ·  30 days

Single edition

$149
$149 per edition
  • Thirty-day supply
  • Distribution free over $60
  • Sixty-day refund window
Subscribe — single edition, $149
Three bottles
Annual standing order  ·  Full course

Annual standing order

$240
$80 per edition  ·  Best value
  • Full twelve-week course
  • Distribution included
  • Sixty-day refund window
  • Priority correspondence
Annual standing order — $240
Two bottles
60-day subscription  ·  60 days

60-day subscription

$180
$90 per edition
  • Sixty-day supply
  • Distribution included
  • Sixty-day refund window
60-day subscription — $180
On subscribing

Subscribe for sixty days. Returned without question.

If the publication does not bring a felt change to the reader's nights or mornings, the editorial office refunds the subscription in full — the bottle is not required to be returned.

Subscribe for sixty days — $180

Distribution within the United States is included on standing orders  ·  Sixty-day refund window